Transforming Growth Factor β Signaling Overcomes Dasatinib Resistance in Lung Cancer

Lung cancer is the second most common cancer and the leading cause of cancer-related deaths. Despite recent advances in the development of targeted therapies, patients with advanced disease remain incurable, mostly because metastatic non-small cell lung carcinomas (NSCLC) eventually become resistant...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordian, Edna, Li, Jiannong, Pevzner, Yuri, Mediavilla-Varela, Melanie, Luddy, Kimberly, Ohaegbulam, Kim, Daniel, Kenyon G., Haura, Eric B., Muñoz-Antonia, Teresita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263601/
https://www.ncbi.nlm.nih.gov/pubmed/25501935
http://dx.doi.org/10.1371/journal.pone.0114131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263601/
https://www.ncbi.nlm.nih.gov/pubmed/25501935
http://dx.doi.org/10.1371/journal.pone.0114131

Ejemplares similares